Abiraterone Acetate Tablet, Film Coated
Product Images NDC 82293-002

9 FDA label images from Novugen Pharma (usa) Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 82293-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novugen Pharma (usa) Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abiraterone Acetate Structural Formula (Structure001)

Abiraterone Acetate Structural Formula (Structure001)
Chemical structure of abiraterone acetate, depicting its molecular arrangement including rings and functional groups.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A survival curve graph showing % survival over time to death in months for Abiraterone Acetate versus Placebo. The x-axis represents time to death in months (0 to 21), and the y-axis represents % survival (0 to 100). The graph compares two groups with patient counts noted below the x-axis.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A survival curve chart comparing the percentage of subjects without death over months from randomization for Abiraterone acetate versus placebo. The x-axis represents months from randomization (0 to 60), and the y-axis shows the percentage of subjects without death (0 to 100%). Two lines represent the survival rates for Abiraterone acetate and placebo groups, with sample sizes listed below the x-axis for each group at different time points.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A Kaplan-Meier survival curve chart comparing the percentage of subjects without radiographic progression or death over time between Abiraterone acetate and placebo groups. The x-axis shows months from randomization (0 to 18), and the y-axis shows the percentage of subjects without radiographic progression or death (0% to 100%). The graph includes the number of subjects at risk at various time points for both groups.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A Kaplan-Meier survival curve chart comparing the percentage survival of subjects without death over months from randomization between Abiraterone Acetate and placebo groups. The graph shows survival decreasing over time for both groups, with Abiraterone Acetate represented by a solid line and placebo by a dashed line. A table below the graph displays the number of subjects at risk at various time points for each group.*
FDA Label Image

Abiraterone Acetate Tablets 250 mg Bottle Label (Image01)

Abiraterone Acetate Tablets 250 mg Bottle Label (Image01)
Packaging label for Abiraterone Acetate Tablets USP, 250 mg film-coated tablets. The label includes a warning for women who are or may be pregnant, stating they should not handle tablets without gloves. The package contains 120 tablets and is distributed by Novugen Pharma (USA) LLC. Storage instructions and dosing reference are provided, with the product made in France.*
FDA Label Image

Abiraterone Acetate Tablets 250 mg Bottle Label (Image250mg V1)

Abiraterone Acetate Tablets 250 mg Bottle Label (Image250mg V1)
Label for Abiraterone Acetate Tablets, USP 250 mg, film-coated tablets, distributed by Novugen Pharma (USA) LLC. The package contains 120 tablets. The label includes dosage and storage instructions, warnings for pregnant women, and is marked Rx only. Made in Malaysia.*
FDA Label Image

Abiraterone Acetate Tablets 500 mg Bottle Label (Image02)

Abiraterone Acetate Tablets 500 mg Bottle Label (Image02)
Label for Abiraterone Acetate Tablets USP 500 mg by Novugen Pharma (USA) LLC, containing 60 film-coated tablets. The label includes storage instructions, a warning for women who are or may be pregnant, distribution details, and handling instructions to swallow the tablet whole without crushing or chewing.*
FDA Label Image

Abiraterone Acetate Tablets 500 mg Bottle Label (Image500mg V1)

Abiraterone Acetate Tablets 500 mg Bottle Label (Image500mg V1)
Label for Abiraterone Acetate Tablets USP 500 mg film-coated oral tablets by Novugen Pharma (USA) LLC. The label includes dosage strength, package quantity of 60 tablets, storage instructions, usage warnings, and distributor information, with a barcode and area marked as unvarnished.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.